Taking antidepressants during pregnancy not associated with neonatal problems at 2-4 weeks

June 01, 2017

CHICAGO --- Babies exposed to an antidepressant or a mood disorder during fetal life did not have any more signs of irritability, difficulty feeding, sleep disturbances and respiratory problems two to four weeks after birth than babies who were not exposed. Instead, the major factor associated with newborn problems was preterm birth, according to a new Northwestern Medicine study.

Similar studies have assessed babies earlier -- less than two weeks -- but this study looked at babies two to four weeks after birth. The additional time led the scientists to determine preterm birth as the main cause of these neonatal signs of agitation, excessive crying, rigidity, tremors and restlessness, typically called Neonatal Discontinuation Syndrome (NDS).

Many women are concerned about taking antidepressants because they've heard the presence of these neonatal signs are more common in babies exposed to antidepressants.

"I believe that is true directly after birth, but this study shows those signs appear to be short-lived," said senior author Dr. Katherine Wisner, the Norman and Helen Asher Professor of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine psychiatrist. "At two to four weeks postpartum, the signs women were reporting to us were more associated with preterm birth rather than whether their babies were exposed."

The additional two weeks also gave parents time to adjust to their newborns at home to better assess if their infants' behaviors were of concern to them. They could look for signs that couldn't be readily assessed during typical, 10- to 15-minute doctor examinations, such as length of sleep post-feeding, fever, projectile vomiting and stool characteristics.

The study was published May 24 in the Journal of Clinical Psychiatry.

"Most pregnant women are naturally going to worry more about their baby's health than their own and might forego taking an antidepressant to avoid these neonatal signs," said first author Amy Yang. "But with the information from this study, they can be reassured that the baby's behavior at two to four weeks after birth is not likely due to exposure to medication or depression."

The researchers studied 214 mothers who were divided into three groups: Women with a mood disorder who were not taking any antidepressants; women with a mood disorder who were taking a serotonin reuptake inhibitor (SRI) antidepressant; women who did not have a mood disorder and were not taking an SRI antidepressant (comparison group).

They evaluated the babies for signs on the Finnegan Scale, which lists 21 symptoms that are most frequently observed in infants who have been exposed to illicit or prescription drugs. The rates of sign presence in the SRI, mood disorder and comparison groups were similar at 34.1 percent, 35.1 percent and 30.4 percent, respectively.

"We observed a significant relationship between Finnegan signs and preterm birth independent of SRI antidepressant exposure," said Yang, biostatistician for Northwestern's Asher Center for the Study and Treatment of Depressive Disorders. "Studies of NDS should consider the contribution of preterm birth to infant behavior."

Northwestern University

Related Preterm Birth Articles from Brightsurf:

Researchers develop app to determine risk of preterm birth
An improved mobile phone app will help identify women who need special treatments at the right time and reduce emotional and financial burden on families and the NHS.

Point-of-care diagnostic for detecting preterm birth on horizon
A new study provides a first step toward the development of an inexpensive point-of-care diagnostic test to assess the presence of known risk factors for preterm birth in resource-poor areas.

WVU biostatistician studies link between microbiome and preterm birth
Pregnant African American women are more likely than white women to give birth prematurely, but they're underrepresented in studies of preterm birth rates.

3D-printed device detects biomarkers of preterm birth
Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy.

Association of quitting smoking during pregnancy, risk of preterm birth
This study of more than 25 million pregnant women reports on rates of smoking cessation at the start of and during pregnancy and also examines the association of quitting cigarette smoking and the risk of preterm birth.

Blood test developed to predict spontaneous preterm birth
Results from a multicenter study show that five circulating microparticle proteins found in first-trimester blood samples may provide important clues about risk of spontaneous preterm birth.

Scientists gain new insight on triggers for preterm birth
A group of scientists led by Ramkumar Menon at The University of Texas Medical Branch at Galveston have gained new insight on a poorly-understood key player in the timing of labor and delivery.

Medically assisted reproduction does not raise risk of preterm birth and low birth weight
Study shows that couples can decide about using medically assisted reproduction free from concerns about increasing the health risks to their baby.

Risk of preterm birth reliably predicted by new test
Scientists at UC San Francisco have developed a test to predict a woman's risk of preterm birth when she is between 15 and 20 weeks pregnant, which may enable doctors to treat them early and thereby prevent severe complications later in the pregnancy.

Preterm birth leaves its mark in the functional networks of the brain
Researchers at the University of Helsinki and the Helsinki University Hospital, Finland, have proven that premature birth has a significant and, at the same time, a very selective effect on the functional networks of a child's brain.

Read More: Preterm Birth News and Preterm Birth Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.